FITC anti-human CD62L [DREG-56] and 2 more items

The University of Virginia awarded contract A207_PO-0471513 to BioLegend Inc. on August 21, 2026, for the procurement of laboratory reagents and biological research materials. The contract, valued at $558.00, involves the delivery of three distinct flow cytometry reagents to Martha Joy Macdonald Spano at the University of Virginia's facilities in Virginia. The three line items include FITC (Fluorescein Isothiocyanate) anti-human CD62L [DREG-56] at $133.70, APC (Allophycocyanin) anti-human CD45 Recombinant [QA21A24] at $157.50, and PE/Cyanine7 anti-human CD163 [GHI/61] at $267.40, each ordered in single-unit quantities.

These monoclonal antibodies and conjugated reagents are standard tools used in immunological research and flow cytometry analysis, targeting specific human cell surface antigens for diagnostic and research applications. The contract represents a straightforward purchase order for research-grade biological products required to support the University of Virginia's ongoing research operations. No information regarding contract duration or performance period is specified in the available contract documentation.